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INTRODUCTION
Acute liver failure (ALF) is an uncommon clinical
syndrome characterized by sudden loss of liver function
in apparently normal person with no pre-existing history
of liver disease.1 Previously labelled as fulminant
hepatic failure (FHF), it causes high mortality as well as
morbidity due to cerebral oedema, bleeding and
infections.2 ALF can be determined by the presence
of deranged coagulation (INR > 1.5), hepatic
encephalopathy and duration of illness ≤ 24 weeks.
This syndrome has a variety of causes like viral
aetiology, drug and toxin induced, metabolic errors,
ischaemia and some rare causes.1 The aetiology of ALF
varies worldwide, for example very high rate of suicidal
acetaminophen overdose in the United Kingdom (UK)
and hardly any case of acetaminophen induced liver
injury from developing countries.3,4 Viral hepatitis is most
common cause for ALF in the last three decades of the
20th century and among the viral aetiology most
common are hepatitis B virus (HBV), hepatitis A virus
(HAV) and in tropical countries hepatitis E (HEV) as well.
The prognosis and severity of ALF is of utmost
importance because this would guide the physician
to transfer these patients to intensive care unit (ICU)
earlier and to an institute where desired management
including liver transplantation is available. In the pre-
liver transplant era, ALF had significantly high mortality
i.e. > 80% of patients with ALF died without liver
transplant.5,6
There are multiple prognosis scores and criteria
available for ALF, but two score have been used
popularly i.e. the King's College Hospital Criteria
(KCHC) and Clichy's criteria.7 Among these two
prognostic criteria, KCHC has been used more
extensively for ALF.5 Utility of these scores has been
checked in European Union (EU) and North America.5,8,9
There are certain limitations of KCHC such as low
sensitivity, few subjective parameters like duration
between hepatic encephalopathy (HE) and jaundice and
grade of HE; moreover, there is a delay in detection of
severity of disease requiring transplantation.10,11 Hence,
there is growing interest to determine better prognostic
criteria/scores for early detection of severity of ALF i.e.
even before the development of HE in order to arrange
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Objective: To compare Model for End-stage Liver Disease Score (MELD Score, MS) and King’s College Hospital (KCH)
criteria for finding correlation of mortality in non-acetaminophen induced acute liver failure (NAI-ALF).
Study Design: An analytical cross-sectional study.
Place and Duration of Study: The Aga Khan University Hospital, Karachi, from 2005 to 2007.
Methodology: The study included patients with NAI-ALF. KCH criteria were labelled as good and bad prognosis groups.
MELD score were calculated by using the MELD calculator. ROC was plotted and sensitivity analysis was done. ETA was
used to see correlation between MELD and KCH.
Results: Ninety-one patients with mean age of 32.5 + 16.3 years were studied; 49 were males (54%). Out of these, 57
patients died (63%); two leading causes of non-acetaminophen induced acute liver failure (NAI-ALF) were hepatitis
hepatitis B virus (HBV) (n = 30, 33%) followed by hepatitis E virus in (n = 23, 25.3%). According to King's College Hospital
(KCH) criteria, 50 patients (88%) who died had bad prognosis and 24 patients (70.6%) who survived had good prognosis.
The ROC determined MELD score of 32 was the best predictor of mortality with sensitivity and specificity of 79% and 71%,
respectively and positive predictive value (PPV) and negative predictive values (NPV) of 82% and 67% respectively. There
was significant association between mortality and bad prognosis according to KCH criteria (p < 0.001). Overall mean
MELD score (MMS) was 35.35 + 8.64. MMS on admission was 38 + 7.32 in patients who died and 30.7 + 8.77 in those
who survived (p = < 0.001). MMS correlated equally with KCH criteria (ETA = 0.52).
Conclusion: The admission MELD score has an excellent utility and correlates equally with KCH criteria for mortality in
NAI- ALF.
Key words: MELD score.   KCH criteria.   Non-Acetaminophen induced acute liver failure.
Department of Medicine, The Aga Khan University Hospital,
Karachi.
Correspondence: Dr. Om Parkash, Gastroenterologist and
Senior Instructor, The Aga Khan University Hospital, Stadium
Road, Karachi.
E-mail: om.parkash@aku.edu
Received August 30, 2011;  accepted May 30, 2012.
for either early shift to intensive care unit or referral to a
liver transplant unit.10
The Model for End-stage Liver Disease (MELD) scoring
system was originally designed for the assessment of
short-term prognosis in patients with chronic liver
disease undergoing a transjugular intrahepatic
portosystemic shunts (TIPS) to reduce portal pressure.12
MELD score is based on three biochemical parameters;
total serum bilirubin, prothrombin time and creatinine.
Now-a-days its use has been expanded to predict
survival in end stage chronic liver disease in general. It
has been applied as a disease severity index in organ
allocation decisions for liver transplantation in patients
with liver cirrhosis and also for short-term mortality
(3 months) in patients waiting for liver transplantation.13,14
Recently MELD score has also been used to determine
the prognosis in patients with acetaminophen and non-
acetaminophen induced ALF in many studies.10,15-17
MELD was implemented in US in 2002 by UNOS for
allocation of liver in patients with chronic liver disease,
waiting for transplant.15,17
This study was conducted to determine the utility of
MELD score and its correlation with KCH in predicting
prognosis in patients with non-acetaminophen induced
acute liver failure (NAI-ALF) and determine the
correlation between MELD and KCH as well as that of
bad prognosis with mortality.
METHODOLOGY
This analytical cross-sectional study was conducted at
the Aga Khan University Hospital (AKUH), Karachi, from
2005 to 2007.
The diagnosis of ALF was based on the definition
proposed by O'Grady and colleagues,18 (deranged
coagulation (INR >1.5), hepatic encephalopathy and
duration of illness < 24 weeks). Initially ALF was defined
by an interval between the onset of illness and
appearance of encephalopathy of 8 weeks or less.1,19
Medical records of consecutive adult patients aged ≥ 14
years, coded as acute liver failure or fulminant hepatic
failure (FHF) were included in this study. Patients with
acute on chronic liver failure were excluded. A data
collection form including demographics, aetiology,
clinical features, laboratory parameters, and outcome
was designed. The data was obtained from the Health
Information Management System (HIMS) department of
the hospital. All patients were offered standard
management, including protein restriction, bowel
decontamination, lactulose, rehydration and acid
suppression by proton pump inhibitor or H2 antagonist.
All patients were admitted to the special care unit (SCU)
and shifted to intensive care unit (ICU) in case they
needed mechanical ventilation. History was obtained
from the patient's attendants, and a detailed clinical
examination was performed at admission. A uniform
management protocol was implemented in each case,
which included monitoring and correction of blood sugar
levels, inotropic support to maintain mean arterial
pressure above 60 mmHg, and mechanical ventilation in
grade III encephalopathy with cerebral oedema;
intravenous mannitol was used to control cerebral
oedema. Prophylactic antibiotics were started at
presentation in all cases (such as ceftriaxone). Antibiotic
therapy was modified based on culture reports.
Antibiotics were continued till neurological recovery and
resolution of evidence of infection was ensured.
Haemodialysis was used whenever required. Neither
liver transplantation nor liver support device were
available at the centre, and each patient was followed-
up until recovery or death.
All patients were categorized in two groups based on
King’s College Hospital criteria i.e. good and bad
prognosis as shown in Table I. Hepatic encephalopathy
(HE) grade I and II were categorized as early HE while
grade III and IV were categorized as advanced HE.
Modified End-stage Liver Disease (MELD) score was
calculated with the help of MELD calculator available
online from United Network of Organ Sharing (UNOS)
(http://www.unos.org/resources/meld-PeldCalculator.asp).
Based on MELD score, patients were divided into group
1 with MELD score < 32 and group 2 with MELD score
> 32, based on previously reported value of MELD for
grouping of ALF patients.10,15 This study was approved
by Ethic Review Committee of the hospital.
Statistical analysis was performed on Statistical
Package for Social Sciences (SPSS version 16) for
windows. Data were summarized as means ± standard
deviation (SD) for continuous variables and as
percentage for categorical variables. Median with inter-
quartile range (IQR) was used for variables which did not
have normal distribution. Student t-test was used for
continuous variables and chi-square test was used for
categorical variables (dichotomous variable). Receiver
operating characteristic (ROC) analysis was used for
determination of threshold values that had discriminated
between KCHC and MELD score. In this analysis, a
score with an area under curve (AUC) between 0.7 and
0.9 is considered to be clinically useful. Best value of
MELD score was determined by ROC. Sensitivity and
specificity of mortality was calculated for MELD score
and for KCHC. Negative and positive predictive values
for mortality were also determined for MELD score and
KCHC. Correlation between the KCHC and MELD score
was determined by ETA. P-value of ≤ 0.05 was
considered as significant.
RESULTS
A total of 91 patients with NAI- ALF were included in the
study. There were 49 males (54%) and median age was
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26 years (IQR 22-40 years). There were 70 patients
(77%) below 40 years of age. Laboratory parameters of
all patients with NAI-ALF are shown in Table II. Fifty-two
patients (57%) had advanced (grade > II) HE at time of
admission while in grade-I 12 (13/5) and 27 (30%) had
grade-II. There were 86 patients (95%) who developed
HE within 7 days of development of jaundice
(hyperacute liver failure). All 91 patients (100%) had
jaundice. NAI-ALF was caused by hepatitis B virus in 30
(33%), hepatitis E virus in 23 (25%), unknown aetiology
in 19 (21%), drug induced in 11 (12%) and rest were
miscellaneous including (HAV n=2, fatty liver of
pregnancy, n=2, CMV n=2, HBV/HDV, n=2). Median
hospital stay for all patients was 6 days (IQR 4-11). A
total of 57 patients died (63%) and among them 50
(88%) were falling in the bad prognosis based on KCH
criteria. Among those survived, 24/34 (77%) had good
prognosis according to KCH criteria. There was a
significantly higher mortality in bad prognosis group
(n=60, p < 0.001) as compared to good prognosis
(n=31). There was significant association between
mortality and bad prognosis according to KCH criteria (p
< 0.001).
Overall mean MELD score was 35.35 ± 8.64. Mean
MELD score at the time of admission was significantly
higher in patients (n=57) who died (38±7.32) as
compared to patients (n=34) who survived (30.7 ± 8.77,
p < 0.001). The ROC was developed to determine the
best predictive value of MELD score shown in Figure 1;
comparison between MELD and KCH is shown in
Figure 2. Mean MELD score fairly correlates with KCH
criteria (ETA=0.52).
DISCUSSION
This is the first study from South Asia assessing the role
of MELD score in ALF as prognostic marker. This study
has shown excellent validity of MELD score (> 32 score)
for death in terms of high sensitivity and specificity.
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Table I: King’s College criteria for acute liver failure (1,3).
Acetaminophen group 
• PH < 7.30 (Irrespective of grade of encephalopathy)        
Or
• Prothrombin time > 100 seconds (INR > 6.5)
• Serum creatinine > 3.4 mg/dl (> 300 Mmol/L) in patients with grade III/IV
encephalopathy
Non acetaminophen group
• Prothrombin time > 100 seconds (INR > 6.5; irrespective of grade of
encephalopathy)
Or 
Any three of following variables
• Age < 10 years or > 40 years
• Cause:
Non-A, non-B hepatitis
Drug induced
Idiosyncratic reactions
• Duration of jaundice before onset of encephalopathy > 7 days
• Prothrombin time > 50 seconds (INR 3.5)
• Serum bilirubin 17.6 mg/dl (> 300 mmol) 
Table II: Demographic, clinical features and laboratory parameters of
cohort with NAI-ALF (patients, n=91).
Variables Values
Complete blood count
•  Haemoglobin (gm/dl) 13.09 gm/dl ± (2.5)^ 
•  TLC (cmm) 14/cmm (11-18)* 
•  PLT (cmm) 194/cmm (125-310)*
Bleeding diathesis 
•  PT in seconds 49 seconds (27-78)*
•  INR 4.8 (IQR 2.7-7)*
Liver Function Test
•  Bilirubin (mg/dl) 16mg/dl(10-24)*
•  SGPT (IU/L) 1267 IU/L (428-2663)*
•  SGOT (IU/L) 796 IU/L (345-1774)*
•  GGT (IU/L) 47 IU/L (30-94)*
•  SAP (IU/L) 164 IU/L (128-224)*
Renal Function
•  S.Cr (mg/dl) 1.48 mg/dl± (0.86)^
•  Arterial pH 7.37 (0.4)^
* Median with interquartile range (IQR);   ^ Mean ± Standard deviation (SD).
Figure 1:  ROC curve of MELD for mortality in NAI-ALF patients.
Figure 2:  ROC comparing MELD with KCH criteria for mortality in NAI- ALF.
 
Similarly, there was a high positive predictive value for
MELD score (> 32 score) as well as for bad prognosis of
KCH criteria for death. Therefore, one can suggest bad
outcome in ALF when MELD score exceeds 32.
Previously, MELD score has been validated as a good
measuring tool to predict mortality in liver cirrhosis for 3
months.13 It has already been used as a predictor of liver
failure and death in acetaminophen induced liver failure
in European studies. Schmidt et al. has not found MELD
score useful in predicting death in acetaminophen
induced ALF than isolated value of INR or KCH criteria;
on the contrary they found it a useful predictor of ALF in
acetaminophen induced liver injury.10 There is very scant
data regarding the use of MELD score in NAI-ALF; a
recent report had suggested that MELD score can be
used as a complement to other prognostic model
especially in NAI-ALF.20
In a recent study on assessment of MELD score at
listing for predicting survival of pre-transplant and post-
transplant patients with ALF on waiting list of United
Network for Organ Sharing (UNOS) as status 1. This
study had suggested that patients who belonged to
NAI-ALF group had poor survival, if liver transplant not
received at 30 days and having negative correlation with
MELD score. Hence, MELD was significantly predicting
survival in NAI-ALF.17 Contrary to this, this study has
shown that MELD score of 32 and KCH criteria has
excellent validity for mortality. Another study from India
also reported that MELD score of 33 is better
discriminator between survival and deaths as depicted
by ROC which is in line with our MELD score cut off.16
Meaningful interpretation of MELD score in ALF is very
critical because it is dependent on bilirubin, creatinine
and prothrombin time (PT). ALF is a dynamic condition
which mainly affects these three major systems.
Therefore, continuous MELD score monitoring is more
practical than KCH criteria. Moreover, theoretically
different cut-offs can be used for different stages of
disease, different populations and different indications.10
Hence, MELD score can be used in patients with severe
acute hepatitis before the onset of HE for proper triage
to deliver better care and for possible liver transplant
where facilities are available. Different cut-offs of MELD
score were used to determine best prognostic value for
mortality, which would have best sensitivity as well as
specificity. This study has shown higher validity scores at
a MELD score of 32 as compared to the study by
Schmidt  et al. who has reported lower validity score i.e.
sensitivity of 58%, specificity of 54%, PPV 59% and NPV
of 53%. Similarly, for KCH criteria, Schmidt et al. study
reported lower validity as compared to this study. The
sensitivity as well as specificity for KCH criteria in
Schmidt et al. study is 67% and 79% respectively and
lower values for NPV and PPV (68 and 79%
respectively). This also confirms that the patients with
NAI-ALF had more severe disease in which MELD score
can do better in predicting prognosis.
There were significant differences among the MELD
score of dead (MMS = 38) and survived (MMS = 30)
patients as compared to Schmidt et al. (MMS = 32 vs.
30). This is important as it can be used as a predictor of
mortality at the time of admission. Recently, another
study by Yantorono et al. has reported that MELD score
of 30 is an excellent prognosis indicator in patients with
ALF both in adults and children.21 They reported NPV of
100% and PPV of 91% while the present study had
reported NPV of 67% and PPV of 82% which is
much lower. Katoonizadeh et al. had shown higher NPV
91% as compared to 67% in this study and lower PPV
(56%) as compared to much higher value (82%) in this
study.15
Survival in the present study was 37% which is
comparable with 34% reported by Schmidt et al.10 Shakil
et al. had reported higher specificity and PPV of KCH for
poor outcome as compared to this report.5 Contrary to
Shakil et al. findings where 96% cases fulfilling KCH
criteria died, mortality was 88% in this study.
There was a significant contribution of viral aetiology in
ALF i.e. > 50% in this cohort as compared to Western
studies in which viral aetiology is lower.5,22 Aetiology of
ALF was indeterminate in a significant proportion of this
group as compared to in Western reports;1 21% in this
cohort as compared to 14% by Lee et al. has unknown
aetiology of ALF.1 Dhimen et al. reported higher (50%)
hepatitis B related ALF,16 while hepatitis E virus was the
causative factor in 25% of our patients. Interestingly
indeterminate group (21%) is slightly higher as
compared to the 19% by Dhiman et al.16 This difference
in aetiological agents from two developing countries has
no scientific explanation, but could be related to a higher
prevalence of hepatitis B in India as compared to
Pakistan.
The patients who survived were younger (p=0.023).
Dhiman et al. also reported similar significant difference
for age in survivors of ALF;16 besides age, the mortality
in two studies were also similar.
Based on the results of sensitivity, specificity and
predictive values of this study and due to a significant
correlation between the MELD score and KCH, it can be
proposed that MELD score can be used for predicting
mortality in NAI-ALF.
The prognosis of ALF depends on many factors like
hepatic regeneration, hepatic failure, brain oedema and
multi-organ failure. There are practical limitations for
MELD because of the dependence on creatinine, INR
and bilirubin. These factors can be corrected with
artificial measures like replacement therapy and plasma
exchange or transfusion. Therefore, this correction could
lead to decreased MELD score leading to seemingly
better score and should be interpreted with caution.10
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CONCLUSION
MELD score can be used complementary to other
prognostic criteria for ALF especially in non-acetaminophen
induced acute liver failure (NAI-ALF). Due to subjective
parameters in KCH criteria, MELD score can replace it
for predicting high risk of death due to NAI-ALF.
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